#checkpoint — Tuesday, June 16, 2026 (1 items)
| 0 | 💬 0 |
TIGIT-targeted IL-12 fusion protein engages NK and CD8(+) T cells for potent tumor immunotherapy.
(linkinghub.elsevier.com)
|
Cell Reports Medicine 2026-06-16 | #cancer #immunotherapy #cytokine #checkpoint |